PDT Partners’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-22,400
| Closed | -$205K | – | 981 |
|
|
2021
Q2 | $205K | Sell |
22,400
-19,353
| -46% | -$177K | 0.01% | 699 |
|
|
2021
Q1 | $208K | Buy |
41,753
+7,653
| +22% | +$38.1K | 0.01% | 696 |
|
|
2020
Q4 | $147K | Sell |
34,100
-5,050
| -13% | -$21.8K | 0.01% | 638 |
|
|
2020
Q3 | $168K | Buy |
39,150
+27,789
| +245% | +$119K | 0.01% | 648 |
|
|
2020
Q2 | $51K | Buy |
+11,361
| New | +$51K | ﹤0.01% | 649 |
|
|
2018
Q3 | – | Sell |
-22,199
| Closed | -$236K | – | 558 |
|
|
2018
Q2 | $236K | Sell |
22,199
-7,500
| -25% | -$79.7K | 0.01% | 459 |
|
|
2018
Q1 | $257K | Sell |
29,699
-300
| -1% | -$2.6K | 0.01% | 504 |
|
|
2017
Q4 | $283K | Sell |
29,999
-17,600
| -37% | -$166K | 0.01% | 485 |
|
|
2017
Q3 | $374K | Buy |
47,599
+18,099
| +61% | +$142K | 0.01% | 460 |
|
|
2017
Q2 | $254K | Buy |
+29,500
| New | +$254K | 0.01% | 465 |
|
|
2014
Q2 | – | Sell |
-11,694
| Closed | -$217K | – | 1727 |
|
|
2014
Q1 | $217K | Buy |
+11,694
| New | +$217K | 0.01% | 1217 |
|